Correlation Engine 2.0
Clear Search sequence regions


  • apoptosis (10)
  • Aquaporin- 3 (12)
  • aquaporins (1)
  • cellular (1)
  • ERK1 (6)
  • fluctuates (1)
  • humans (1)
  • lentivirus (1)
  • Sizes of these terms reflect their relevance to your search.

    Intervertebral disc degeneration (IDD) is closely related to osmolarity, which fluctuates with daily activities, and hyperosmolarity may be a contributor to nucleus pulposus (NP) cells apoptosis. Aquaporin-3 (AQP-3) belongs to the family of aquaporins and mainly transports water and other small molecular proteins, which is reduced with the aging of the intervertebral disc. ERK1/2 pathway is one type of mitogen-activated protein kinase (MAPK) and is associated with cellular apoptosis. This study was aimed to investigate the effects of AQP-3 on NP cells apoptosis induced by a hyperosmolarity and focused on the role of the ERK1/2 signaling pathway. We found that NP apoptosis could be induced by hyperosmolarity (550 mOsm/kg), and downregulation of AQP-3 and inhibition of ERK1/2 could be simultaneously observed. Therefore, lentivirus was used to enhance the expression of AQP-3 to compare apoptosis between AQP-3-overexpressed NP cells and the control NP cells. The results showed that apoptosis could be alleviated by overexpression of AQP-3 and the activity of ERK1/2 could also be promoted. Furthermore, we found that the inhibitor U0126 could partly aggravate apoptosis of the AQP-3-overexpressed NP cells. In summary, our results suggested that overexpression of AQP-3 could protect against hyperosmolarity-induced NP cell apoptosis via promoting the activity of the ERK1/2 pathway. This study may shed light on a better understanding of the pathologic mechanism of IDD and bring AQP-3 into the therapeutic approaches for IDD treatment. Copyright © 2022 Zetong Zhang et al.

    Citation

    Zetong Zhang, Chen Zhao, Ruijie Zhang, Yiyang Wang, Yanzhu Hu, Qiang Zhou, Pei Li. Overexpression of Aquaporin-3 Alleviates Hyperosmolarity-Induced Nucleus Pulposus Cell Apoptosis via Regulating the ERK1/2 Pathway. Pain research & management. 2022;2022:1639560

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 35437455

    View Full Text